Selective early production of CCL20, or macrophage inflammatory protein 3α, by human mast cells in response to Pseudomonas aeruginosa

Infection and Immunity

Volumn 71, Issue 1, 2003, Pages 365-373

  Lin, Tong Jun ^a   Maher, Lauren H ^a   Gomi, Kaede ^a   McCurdy, Jeffrey D ^a   Garduno, Rafael ^a   Marshall, Jean S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; CALCIUM IONOPHORE; CYCLOSPORIN; DEXAMETHASONE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C INHIBITOR;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELL LINE; CELLS, CULTURED; CHEMOKINES, CC; CYCLOSPORINE; DEXAMETHASONE; FETAL BLOOD; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; MACROPHAGE INFLAMMATORY PROTEINS; MAST CELLS; PROTEIN KINASE C; PSEUDOMONAS AERUGINOSA; RECEPTORS, CHEMOKINE;

EID: 0037218169     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.1.365-373.2003     Document Type: Article

References (67)

1. Abraham, S. N., and R. Malaviya. 1997. Mast cells in infection and immunity. Infect. Immun. 65:3501-3508.
2. Agis, H., W. Fureder, H. C. Banld, M. Kundi, W. R. Sperr, M. Willheim, G. Boltz-Nitulescu, J. H. Butterfield, K. Kishi, K. Lechner, and P. Valent. 1996. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology 87:535-543.
3. AI-Aoukaty, A., B. Rolstad, A. Giaid, and A. A. Maghazachi. 1998. MIP-3alpha, MIP-3beta and fractalkine induce the locomotion and the mobilization of intracellular calcium, and activate the heterotrimeric G proteins in human natural killer cells. Immunology 95:618-624.
4. Baba, M., T. Imai, M. Nishimura, M. Kakizaki, S. Takagi, K. Hieshima, H. Nomiyama, and O. Yoshie. 1997. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J. Biol. Chem. 272:14893-14898.
5. Bergmann, U., J. Scheffer, M. Koller, W. Schonfeld, G. Erbs, F. E. Muller, and W. Konig. 1989. Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients. Infect. Immun. 57:2187-2195.
6. Bermudez, L. E., J. C. Martinelli, R. Gascon, M. Wu, and L. S. Young. 1990. Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor. Cytokine 2:287-293.
7. Boudreau, R. T., R. Garduno, and T. J. Lin. 2002. Protein phosphatase 2A and protein kinase C alpha are physically associated and are involved in Pseudomonas aeruginosa-induced interleukin 6 production by mast cells. J. Biol. Chem. 277:5322-5329.
8. Chang, E. Y., Z. Szallasi, P. Acs, V. Raizada, P. C. Wolfe, C. Fewtrell, P. M. Blumberg, and J. Rivera. 1997. Functional effects of overexpression of protein kinase C-alpha, -beta, -delta, -epsilon, and -eta in the mast cell line RBL-2H3. J. Immunol. 159:2624-2632.
9. Cook, D. N., D. M. Prosser, R. Forster, J. Zhang, N. A. Kuklin, S. J. Abbondanzo, X. D. Niu, S. C. Chen, D. J. Manfra, M. T. Wiekowski, L. M. Sullivan, S. R. Smith, H. B. Greenberg, S. K. Narula, M. Lipp, and S. A. Lira. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12:495-503.
10. Cripps, A. W., M. L. Dunkley, R. L. Clancy, and J. Kyd. 1995. Pulmonary immunity to Pseudomonas aeruginosa. Immunol. Cell. Biol. 73:418-424.
11. Dieu, M. C., B. Vanbervliet, A. Vicari, J. M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque, and C. Caux. 1998. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188:373-386.
12. Dixon, D. M., and M. L. Misfeldt. 1995. GM-CSF is required for the Pseudomonas exotoxin A-induced proliferation of immature T cells in athymic mice. Cell. Immunol. 160:65-70.
13. Echtenacher, B., D. N. Mannel, and L Hultner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75-77.
14. Fox, B., T. B. Bull, and A. Guz. 1981. Mast cells in the human alveolar wall: An electronmicroscopic study. J. Clin. Pathol. 34:1333-1342.
15. Friedl, P., B. Konig, and W. Konig. 1992. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells. Immunology 76:86-94.
16. Furitsu, T., T. Tsujimura, T. Tono, H. Ikeda, H. Kitayama, U. Koshimizu, H. Sugahara, J. H. Butterfield, L. K. Ashman, Y. Kanayama, et al. 1993. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J. Clin. Investig. 92:1736-1744.
17. Galli, S. J., M. Maurer, and C. S. Lantz. 1999. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 11:53-59.
18. Gordon, J. R., and S. J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 346:274-276.
19. Greaves, D. R., W. Wang, D. J. Dairaghi, M. C. Dieu, B. Saint-Vis, K. Franz-Bacon, D. Rossi, C. Caux, T. McClanahan, S. Gordon, A. Zlotnik, and T. J. Schall. 1997. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3 alpha and is highly expressed in human dendritic cells. J. Exp. Med. 186:837-844.
20. Gupta, A. A., I. Leal-Berumen, K. Croitoru, and J. S. Marshall. 1996. Rat peritoneal mast cells produce IFN-gamma following IL-12 treatment but not in response to IgE-mediated activation. J. Immunol. 157:2123-2128.
21. Harant, H., S. A. Eldershaw, and I. J. Lindley. 2001. Human macrophage inflammatory protein-3alpha/CCL20/LARC/Exodus/SCYA20 is transcriptionally upregulated by tumor necrosis factor-alpha via a non-standard NF-kappaB site. FEBS Lett. 509:439-445.
22. Henderson, W. R., Jr., and E. Y. Chi. 1992. Degranulation of cystic fibrosis nasal polyp mast cells. J. Pathol. 166:395-404.
23. Hieshima, K., T. Imai, G. Opdenakker, J. Van Damme, J. Kusuda, H. Tei, Y. Sakaki, K. Takatsuki, R. Miura, O. Yoshie, and H. Nomiyama. 1997. Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J. Biol. Chem. 272: 5846-5853.
24. Hoffman, P. S., C. A. Butler, and F. D. Quinn. 1989. Cloning and temperature-dependent expression in Escherichia coli of a Legionella pneumophila gene coding for a genus-common 60-kilodalton antigen. Infect. Immun. 57: 1731-1739.
25. Homey, B., M. C. Dieu-Nosjean, A. Wiesenborn, C. Massacrier, J. J. Pin, E. Oldham, D. Catron, M. E. Buchanan, A. Muller, R. deWaal Malefyt, G. Deng, R. Orozco, T. Ruzicka, P. Lehmann, S. Lebecque, C. Caux, and A. Zlotnik. 2000. Up-regulation of macrophage inflammatory protein-3 alpha/ CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164:6621-6632.
26. Hromas, R., P. W. Gray, D. Chantry, R. Godiska, M. Krathwohl, K. Fife, G. I. Bell, J. Takeda, S. Aronica, M. Gordon, S. Cooper, H. E. Broxmeyer, and M. J. Klemsz. 1997. Cloning and characterization of exodus, a novel beta-chemokine. Blood 89:3315-3322.
27. Kamath, S., V. Kapatral, and A. M. Chakrabarty. 1998. Cellular function of elastase in Pseudomonas aeruginosa: Role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol. Microbiol. 30:933-941.
28. Kerem, E. 1997. The role of Pseudomonas aeruginosa in the pathogenesis of lung disease in cystic fibrosis: More questions than answers. Pediatr. Pulmonol. Suppl. 16:265-266.
29. Koch, C., and N. Hoiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341: 1065-1069.
30. Leal-Berumen, I., P. Conlon, and J. S. Marshall. 1994. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152:5468-5476.
31. Liao, F., R. Alderson, J. Su, S. J. Ullrich, B. L. Kreider, and J. M. Farber. 1997. STRL22 is a receptor for the CC chemokine MIP-3alpha. Biochem. Biophys. Res. Commun. 236:212-217.
32. Liao, F., R. L. Rabin, C. S. Smith, G. Sharma, T. B. Nutman, and J. M. Farber. 1999. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J. Immunol. 162:186-194.
33. Lin, T. J., and A. D. Befus. 1997. Differential regulation of mast cell function by IL-10 and stem cell factor. J. Immunol. 159:4015-4023.
34. Lin, T. J., Z. Gao, M. Arock, and S. N. Abraham. 1999. Internalization of FimH+ Escherichia coli by the human mast cell line (HMC-1 5C6) involves protein kinase C. J. Leukoc. Biol. 66:1031-1038.
35. Lin, T. J., T. B. Issekutz, and J. S. Marshall. 2000. Human mast cells transmigrate through human umbilical vein endothelial monolayers and selectively produce IL-8 in response to stromal cell-derived factor-1 alpha. J. Immunol. 165:211-220.
36. Lippert, U., S. Kruger-Krasagakes, A. Moller, U. Kiessling, and B. M. Czarnetzki. 1995. Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp. Dermatol. 4:272-276.
37. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381:77-80.
38. Marshall, J. S., I. Leal-Berumen, L. Nielsen, M. Glibetic, and M. Jordana. 1996. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Investig. 97:1122-1128.
39. Mayer, P., E. Schutze, C. Lam, F. Kricek, and E. Liehl. 1991. Recombinant murine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice. J. Infect. Dis. 163:584-590.
40. Medzhitov, R., and C. A. Janeway, Jr. 1997. Innate immunity: Impact on the adaptive immune response. Curr. Opin. Immunol. 9:4-9.
41. Mellstedt, H., J. Fagerberg, J. E. Frodin, L. Henriksson, A. L. Hjelm-Skoog, M. Liljefors, P. Ragnhammar, J. Shetye, and A. Osterborg. 1999. Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors. Curr. Opin. Hematol. 6:169-175.
42. Nechushtan, H., M. Leitges, C. Cohen, G. Kay, and E. Razin. 2000. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cβ. Blood 95:1752-1757.
43. Osika, E., J. M. Cavaillon, K. Chadelat, M. Boule, C. Fitting, G. Tournier, and A. Clement. 1999. Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur. Respir. J. 14:339-346.
44. Pasculle, A. W., J. C. Feeley, R. J. Gibson, L. G. Cordes, R. L. Myerowitz, C. M. Patton, G. W. Gorman, C. L. Carmack, J. W. Ezzell, and J. N. Dowling. 1980. Pittsburgh pneumonia agent: Direct isolation from human lung tissue. J. Infect. Dis. 141:727-732.
45. Pedersen, C., H. Permin, P. Stahl Skov, S. Norn, M. Svenson, H. Mosbech, and K. Bendtzen. 1985. Inhibitory effect of cyclosporin A on histamine release from human leukocytes and rat mast cells. Allergy 40:103-107.
46. Pennington, J. E. 1990. Pseudomonas aeruginosa. Vaccines and immunotherapy. Infect. Dis. Clin. North Am. 4:259-270.
47. Rossi, D. L., A. P. Vicari, K. Franz-Bacon, T. K. McClanahan, and A. Zlotnik. 1997. Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3α and MIP-3β. J. Immunol. 158:1033-1036.
48. Royer, B., S. Varadaradjalou, P. Saas, J. J. Guillosson, J. P. Kantelip, and M. Arock. 2001. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 31:694-704.
49. Saito, H., M. Ebisawa, H. Tachimoto, M. Shichijo, K. Fukagawa, K. Matsumoto, Y. Iikura, T. Awaji, G. Tsujimoto, M. Yanagida, H. Uzumaki, G. Takahashi, K. Tsuji, and T. Nakahata. 1996. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J. Immunol. 157:343-350.
50. Schleimer, R. P., E. S. Schulman, D. W. MacGlashan, Jr., S. P. Peters, E. C. Hayes, G. K. Adams III, L. M. Lichtenstein, and N. F. Adkinson, Jr. 1983. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J. Clin. Investig. 71:1830-1835.
51. Schwartz, L. B., K. F. Austen, and S. I. Wasserman. 1979. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J. Immunol. 123:1445-1450.
52. Shannon, M. F., S. R. Himes, and L. S. Coles. 1995. GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells. J. Leukoc. Biol. 57:767-773.
53. Shibata, Y., P. Y. Berclaz, Z. C. Chroneos, M. Yoshida, J. A. Whitsett, and B. C. Trapnell. 2001. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 15:557-667.
54. Sierro, F., B. Dubois, A. Coste, D. Kaiserlian, J. P. Kraehenbuhl, and J. C. Sirard. 2001. Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc. Natl. Acad. Sci. USA 98:13722-13727.
55. Song, Z., H. K. Johansen, V. Faber, C. Moser, A. Kharazmi, J. Rygaard, and N. Hoiby. 1997. Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats. Antimicrob. Agents Chemother. 41:961-964.
56. Song, Z. J., H. K. Johansen, V. Faber, and N. Hoiby. 1997. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS 105:438-444.
57. Sullivan, S. K., D. A. McGrath, F. Liao, S. A. Boehme, J. M. Farber, and K. B. Bacon. 1999. MIP-3alpha induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK). J. Leukoc. Biol. 66:674-682.
58. Tam, M., G. J. Snipes, and M. M. Stevenson. 1999. Characterization of chronic bronchopulmonary Pseudomonas aeruginosa infection in resistant and susceptible inbred mouse strains. Am. J. Respir. Cell. Mol. Biol. 20:710-719.
59. Tanaka, T., S. Okamura, K. Okada, A. Suga, N. Shimono, N. Ohhara, Y. Hirota, Y. Sawae, and Y. Niho. 1989. Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice. Infect. Immun. 57:1792-1799.
60. Tanaka, Y., T. Imai, M. Baba, I. Ishikawa, M. Uehira, H. Nomiyama, and O. Yoshie. 1999. Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans. Eur. J. Immunol. 29:633-642.
61. Tarr, P. E. 1996. Granulocyte-macrophage colony-stimulating factor and the immune system. Med. Oncol. 13:133-140.
62. van Heeckeren, A. M., J. Tscheikuna, R. W. Walenga, M. W. Konstan, P. B. Davis, B. Erokwu, M. A. Haxhiu, and T. W. Ferkol. 2000. Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am. J. Respir. Crit. Care Med. 161:271-279.
63. Warbrick, E. V., A. L. Thomas, and C. M. Williams. 1997. The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line. Toxicology 116:211-218.
64. Weber, S., M. Babina, S. Kruger-Krasagakes, A. Grutzkau, and B. M. Henz. 1996. A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch. Dermatol. Res. 288:778-782.
65. Wershil, B. K., G. T. Furuta, J. A. Lavigne, A. R. Choudhury, Z. S. Wang, and S. J. Galli. 1995. Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades by multiple mechanisms. Int. Arch. Allergy Immunol. 107:323-324.
66. Wershil, B. K., G. T. Furuta, J. A. Lavigne, A. R. Choudhury, Z. S. Wang, and S. J. Galli. 1995. Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol. 154:1391-1398.
67. Zlotnik, A., and O. Yoshie. 2000. Chemokines: A new classification system and their role in immunity. Immunity 12:121-127.